Condition
Aspirin Exacerbated Respiratory Disease
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Suspended1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04375293Not ApplicableCompletedPrimary
Characterisation of the Nasal Microbiome in Patients With N-ERD
NCT04261582SuspendedPrimary
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
NCT01778465Not ApplicableCompleted
Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease
NCT01540032Not ApplicableUnknownPrimary
Low Salicylate Diet in Aspirin Exacerbated Respiratory Disease
Showing all 4 trials